Trial Profile
Prospective single-centre study investing the effect of genetic variations in transforming growth factor-β (TGF-β) on the clinical outcomes of gefitinib treatment of advanced lung adenocarcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Adenocarcinoma
- Focus Therapeutic Use
- 30 Dec 2015 New trial record